Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study

BACKGROUND: Docetaxel (DTX) is a widely used anti-tumour drug, and its dosage is solely determined by body surface area (BSA). Adverse events, such as neutropenia or unsatisfied efficacy, likely occur because of differences in the pharmacokinetics (PK) and pharmacodynamics of patients. Thus, a feasi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transl Med
Main Authors: Sun, Ning, Shen, Bo, Zhu, Jiali, Zhang, Xiaomei, Zhu, Huayun, Liang, Geyu, Yang, Deliang, Lu, Jianwei, Zhang, Yan
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282138/
https://ncbi.nlm.nih.gov/pubmed/32513288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02394-w
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares